Klara Dickinson Insider Trading
Get free email notifications about insider trading for Klara Dickinson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Klara Dickinson. Klara Dickinson is a Chief Regulatory Officer in CymaBay Therapeutics, Inc. ($CBAY) and a See Remarks in CymaBay Therapeutics, Inc. ($CBAY) and a SVP, Regulatory Affairs & QA in CymaBay Therapeutics, Inc. ($CBAY) and a SVP, Regulatory and Quality in CymaBay Therapeutics, Inc. ($CBAY) and a Chief Regulatory Officer in Anthera Pharmaceuticals Inc ($ANTH).
Address: 5000 SHORELINE COURT, SUITE 101 SOUTH SAN FRANCISCO 94080 CA
Companies in which Klara Dickinson is an Insider
Anthera Pharmaceuticals Inc
Trading Symbol: ANTHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Klara Dickinson: Chief Regulatory Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 22 2017
$ANTH Market Capitalization: $23.84M
$ANTH Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CymaBay Therapeutics, Inc.
Trading Symbol: CBAYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Klara Dickinson: See Remarks, Chief Regulatory Officer, SVP, Regulatory and Quality, SVP, Regulatory Affairs & QA
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 28 2021
$CBAY Market Capitalization: $52.52M
$CBAY Previous Close: $2.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Klara Dickinson
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2021 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 5.78 | 66,500 | 384,370 | 66,500 | |
May 19 2020 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | See Remarks | Option Exercise | A | 4.05 | 328,299 | 1,329,611 | 328,299 | |
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 8.43 | 138,312 | 1,165,970 | 138,312 | |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | SVP, Regulatory and ... | Option Exercise | A | 11.69 | 100,000 | 1,169,000 | 100,000 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | Dickinson Klara | SVP, Regulatory Aff ... | Option Exercise | A | 5.50 | 200,000 | 1,100,000 | 200,000 | |
May 22 2017 | ANTH | Anthera Pharmaceut ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 1.63 | 43,750 | 71,313 | 43,750 | |
Jun 13 2016 | ANTH | Anthera Pharmaceut ... | Dickinson Klara | Chief Regulatory Of ... | Option Exercise | A | 3.52 | 105,000 | 369,600 | 105,000 |